‘Undruggable’ Parkinson’s Molecule Spills Its Secrets
This article is archived and only made available for historical reference. If you’d like to discover UCSF’s most recent advances in research, education and patient care, please visit the UCSF News Center. UC San Francisco researchers have for the first time developed a strategy for targeting a key molecule implicated in Parkinson’s disease, opening up a potential new treatment strategy for the currently incurable movement disorder.
- ▪This article is archived and only made available for historical reference.
- ▪If you’d like to discover UCSF’s most recent advances in research, education and patient care, please visit the UCSF News Center.
- ▪UC San Francisco researchers have for the first time developed a strategy for targeting a key molecule implicated in Parkinson’s disease, opening up a potential new treatment strategy for the currently incurable movement disorder.
UCSF News files mainly under design. We currently carry 50 of its stories.
Opening excerpt (first ~120 words) tap to expand
This article is archived and only made available for historical reference. If you’d like to discover UCSF’s most recent advances in research, education and patient care, please visit the UCSF News Center. Research March 6, 2019 Archive: ‘Undruggable’ Parkinson’s Molecule Spills Its Secrets Successful Pharmacological Activation of Nurr1 Opens Doors to Novel Therapies for Incurable Movement Disorder By Nicholas Weiler Share on Facebook Share on Twitter Share on Reddit Email this article Print this article Researchers identified a hidden drug target (yellow) on a neuronal protein (blue) that has long been implicated in Parkinson’s disease but was previously considered “undruggable.” Credit: England lab/UCSF.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at UCSF News.